NCT00000378View on ClinicalTrials.gov

Antidepressant Treatment of Melancholia in Late Life

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 31, 1997

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
DepressionMelancholia
Interventions
DRUG

Sertraline

12 week trial dose up to 200mgs

DRUG

Nortriptyline

12 week trial dose adjusted to therapeutic level

Trial Locations (1)

10032

1051 Riverside Drive, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00000378 - Antidepressant Treatment of Melancholia in Late Life | Biotech Hunter | Biotech Hunter